Prediction of Renal Parenchymal Damage of CAKUT

CompletedOBSERVATIONAL
Enrollment

234

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
CAKUT
Interventions
DIAGNOSTIC_TEST

combined diagnosis of renal parenchymal damage

"This study is an observational study to evaluate the accuracy of renal parenchymal damage combined diagnosis with no intervention. All patients from the cohort accept MRI-DWI scan,the urinary biomarkers detection, disease gene detection and DMSA scan.~1. This combined diagnosis includes MRI-DWI scan and the urinary biomarkers detection.~ MRI-DWI: All the scans are performed using the MagnetomVerio 3.0T magnetic resonance imaging system from Siemens.~ Urinary polypeptide collection: Urine samples requirements: volume between 50-100ml, specific gravity \>1.010. Immunomagnetic beads isolation technique is used to collect polypeptide.~2. The reference standard is DMSA scan: Intravenous injection of 99mTC-DMSA5mCi is followed by anterior and posterior planar imaging of the renal area 1 hour later. The DMSA scan images are read by 2 trained radiologists and confirmed by the special doctor of the center for diagnosis and treatment of renal and urinary diseases at the same time."

Trial Locations (1)

Unknown

Children's Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER

NCT04537364 - Prediction of Renal Parenchymal Damage of CAKUT | Biotech Hunter | Biotech Hunter